FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34814611000001106: Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Nov 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105538801000001114 Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105538901000001115 Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet Is a Ribociclib 200mg tablets 21 tablet true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet Has AMP Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet Has specific active ingredient Ribociclib succinate true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ribociclib true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 21 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start